The Therapeutic Goods
Administration has added Translarna
(atalauren) and Cystadrops
(mercaptamine hydrochloride) to its
list of designated orphan drugs.
Translarna is indicated for
the treatment of patients with
Duchenne muscular dystrophy
resulting from a nonsense mutation
in the dystrophin gene, while
Cystadrops eye drops solution is for
the treatment of corneal cystine
deposits in cystinosis.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.